Last updated
Advent: M&A Activity
Advent, a global private equity investor, has acquired a majority stake in New Zealand Clinical Research Group (NZCR Group), a clinical trials and medical research organisation operating in New Zealand and Australia. Transaction terms were not disclosed.
Source: discovered:businessdesk.co.nz
- What happened
- Advent, a global private equity investor, has acquired a majority stake in New Zealand Clinical Research Group (NZCR Group), a clinical trials and medical research organisation operating in New Zealand and Australia. Transaction terms were not disclosed.
- Who
- Advent · New Zealand
- When
- 2026-08-20
- So what
- Consolidation shifts the leadership question from growth to integration.
The leadership read
Consolidation shifts the leadership question from growth to integration. For Advent in the sector, the demand moves toward transformation and integration leaders who can merge teams, systems and cultures without losing momentum. Across Oceania, watch whether the integration is properly resourced; deals are won or lost the year after they close.
Market context: Backdrop: a 122.7 (Hot) Talent Market Index (up 17.8 on the month) with Oceania activity easing (-24.9pts).
Advent: 2 signals in the last 90 days; 4 tracked across 148 days.
MitchelLake in this thematic
Also at Advent →
More signals across Oceania
M&A Activity · Oceania
RAS Technology →Takeover activity around ASX-listed RAS Technology (ASX:RTH), with PA Media apparently the party behind the approach.
M&A Activity · Oceania
AustralianSuper →AustralianSuper increased its investment in Perth Airport by acquiring two co-investors' stakes, bringing its holding to around 29.4%.
M&A Activity · Oceania
TAL Daiichi Life Australia →TAL Daiichi Life Australia has launched a A$7.8 billion takeover bid for Challenger, an Australian listed life insurer and asset manager.
M&A Activity · Oceania
Genetic Signatures →Genetic Signatures (ASX:GSS) has a proposed scheme of arrangement to merge with Microba Life Sciences (ASX:MAP). A rival shareholder, BCAL Diagnostics (ASX:BDX), with a combined stake of about 23.3% alongside Capital Property Corporation, is seeking to remove two Genetic directors at an upcoming EGM and has been asked to declare its merger intentions.
M&A Activity · Oceania
SG Fleet Management →SG Fleet Management has made a reported $1.1b takeover bid for ASX-listed FleetPartners (ASX:FPR), a fleet-leasing consolidation move.
M&A Activity · Oceania
New Hope Corporation →New Hope Corporation is pursuing a roughly A$1.8b takeover of Malabar, an ASX-listed coal company, continuing a pattern of coal-sector consolidation.
Where this lands in our work
- Private Equity →
Ownership change resets the executive requirement — value-creation leadership follows the deal.
- Executive Search: Oceania →
Our Oceania practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗